28479-19-8

Applied Filters:

Keyword:'28479-19-8'

Showing 1-10 of 834 results for "28479-19-8" within Site Content

TSCA 8 Notification

Submit notification of unreported health effect

Merck & Baylor College Covid-19 Collaboration

Merck and Baylor College extend collaboration to accelerate Covid-19 manufacturing platform for Phase 1 clinical trials.

Color Determination of Sugar Based on ICUMSA method GS9-8

Discover the ICUMSA® method GS9-8 (2011) to determine the color of sugar solutions with color indices ranging from 10 to 16 000 IU.

Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine

Merck and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.

Merck Supports Eijkman Institute to Expedite Covid-19 Vaccine Development Research

Merck today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia.

Merck funds Indian Institute of Technology (IIT) Bombay for Covid-19 research

Merck today announced a donation of INR 1.7crore (194,000€) over two years to the Indian Institute of Technology (IIT), Bombay to support the development of clinical tests for Covid-19 disease severity assessment.

Coronavirus COVID-19 (SARS-CoV-2) Detection, Characterization, Vaccine and Therapy Production

We've consolidated our COVID-19 detection, characterization, and vaccine production product offers to help researchers responding to the coronavirus pandemic.

MILLIPLEX® Multiplex Assays for COVID-19 (SARS-CoV-2) Research Applications

MILLIPLEX® multiplex assays help to better understand the immune response to COVID-19 (SARS-CoV-2), including cytokine storm. Our MILLIPLEX® multiplex immunoassays offer researchers the ability to simultaneously quantitate a large number of analytes critical to understanding the immune response in humans.

Certified Reference Materials for ¹⁹F NMR

Introduction of 19F qNMR certified reference materials for complex molecule certification.

Biopharma Pandemic Learnings: Regulatory Evolution

The Economist Impact report explores COVID-19's effect on biopharma regulatory landscape and collaboration.

Page 1 of 84